Data registry to capture real-world evidence of canaloplasty
Click Here to Manage Email Alerts
Nova Eye Medical has established the iTrack Global Data Registry, which will collect prospective data on canaloplasty in the treatment of glaucoma, according to a press release.
The registry is a collaboration with the International Glaucoma Surgery Registry and will document real-world clinical evidence on the iTrack and iTrack Advance across North America, Europe and the Asia Pacific region.
“The iTrack Global Data Registry is providing high-quality, real-world evidence of the effectiveness and safety of canaloplasty to treat glaucoma and ocular hypertension,” Nathan Kerr, BHB, MBChB, MD, FRANZCO, said in the release. “Importantly, it provides a robust means by which to collect uniform data to evaluate specified outcomes across the spectrum of glaucoma. It will make a major contribution to our understanding of the clinical effectiveness of canaloplasty and will enable evidence-based decision-making.”
Ike K. Ahmed, MD, FRCSC, and David Lubeck, MD, will join Kerr in leading the registry.
Nova Eye Medical said the iTrack registry will follow canaloplasty outcomes for a minimum of 24 months and include more than 300 patients.
Read more about
Click Here to Manage Email Alerts